Research Article
Nerolidol Suppresses the Inflammatory Response during Lipopolysaccharide-Induced Acute Lung Injury via the Modulation of Antioxidant Enzymes and the AMPK/Nrf-2/HO-1 Pathway
Figure 8
Scheme of the mechanisms in the protective effect of nerolidol on LPS-induced ALI.